Literature DB >> 29700044

Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis.

J-M Tillema1, S D Weigand2, M Dayan3, Y Shu4, O H Kantarci3, C F Lucchinetti3, J D Port4.   

Abstract

BACKGROUND AND
PURPOSE: The 2010 McDonald criteria are designed to sensitively detect MS; however, the low specificity of these criteria can occasionally lead to the misdiagnosis of MS. The purpose of this study was to determine whether a novel double inversion recovery MR imaging technique has the potential to increase the specificity of diagnostic criteria distinguishing MS from non-MS white matter lesions.
MATERIALS AND METHODS: This was a cross-sectional observational study. MR imaging data were acquired between 2011 and 2016. A novel double inversion recovery sequence that suppresses CSF and GM signal was used (GM-double inversion recovery). We compared WM lesions in a group of patients with multiple sclerosis and in a second group of positive controls with white matter lesions who did not have a diagnosis of MS. The presence of a rim on the GM-double inversion recovery MR imaging sequence was combined with the 2001 and 2010 McDonald disseminated-in-space criteria. Multiple MR imaging markers, including lesion location, size, and the presence of a rim, were compared between groups as well as a quantitative measure of lesion T1 hypointensity.
RESULTS: MR images from 107 patients with relapsing-remitting MS (median age, 32 years) and 36 positive control (median age, 39 years) subjects were analyzed. No significant differences were found in age and sex. In patients with MS, 1120/3211 lesions (35%) had a rim on GM-double inversion recovery; the positive control group had only 9/893 rim lesions (1%). Rims were associated with a decrease in the lesion T1 ratio. Using the 2010 MR imaging criteria plus the presence of rims on GM-double inversion recovery, we achieved 78% and 97% specificity in subjects with ≥1 and ≥2 rim lesions, respectively.
CONCLUSIONS: The addition of a novel GM-double inversion recovery technique enhanced specificity for diagnosing MS compared with established MR imaging criteria.
© 2018 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2018        PMID: 29700044      PMCID: PMC6002880          DOI: 10.3174/ajnr.A5636

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  33 in total

1.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

2.  Bayesian analysis of neuroimaging data in FSL.

Authors:  Mark W Woolrich; Saad Jbabdi; Brian Patenaude; Michael Chappell; Salima Makni; Timothy Behrens; Christian Beckmann; Mark Jenkinson; Stephen M Smith
Journal:  Neuroimage       Date:  2008-11-13       Impact factor: 6.556

3.  Multiple sclerosis or multiple possibilities: the continuing problem of misdiagnosis.

Authors:  Richard A Rudick; Aaron E Miller
Journal:  Neurology       Date:  2012-05-11       Impact factor: 9.910

4.  Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

Authors:  B Fischl; M I Sereno; A M Dale
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

5.  The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Authors:  Andrew J Solomon; Dennis N Bourdette; Anne H Cross; Angela Applebee; Philip M Skidd; Diantha B Howard; Rebecca I Spain; Michelle H Cameron; Edward Kim; Michele K Mass; Vijayshree Yadav; Ruth H Whitham; Erin E Longbrake; Robert T Naismith; Gregory F Wu; Becky J Parks; Dean M Wingerchuk; Brian L Rabin; Michel Toledano; W Oliver Tobin; Orhun H Kantarci; Jonathan L Carter; B Mark Keegan; Brian G Weinshenker
Journal:  Neurology       Date:  2016-08-31       Impact factor: 9.910

6.  Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis?

Authors:  Nina Lummel; Tobias Boeckh-Behrens; Veronika Schoepf; Michael Burke; Hartmut Brückmann; Jennifer Linn
Journal:  Neuroradiology       Date:  2010-06-29       Impact factor: 2.804

7.  Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

Authors:  Frederik Barkhof; Wolfgang Bruck; Corline J A De Groot; Elisabeth Bergers; Sandra Hulshof; Jeroen Geurts; Chris H Polman; Paul van der Valk
Journal:  Arch Neurol       Date:  2003-08

8.  Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.

Authors:  Niraj Mistry; Rasha Abdel-Fahim; Amal Samaraweera; Olivier Mougin; Emma Tallantyre; Christopher Tench; Tim Jaspan; Peter Morris; Paul S Morgan; Nikos Evangelou
Journal:  Mult Scler       Date:  2015-12-10       Impact factor: 6.312

9.  Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.

Authors:  Assunta Dal-Bianco; Günther Grabner; Claudia Kronnerwetter; Michael Weber; Romana Höftberger; Thomas Berger; Eduard Auff; Fritz Leutmezer; Siegfried Trattnig; Hans Lassmann; Francesca Bagnato; Simon Hametner
Journal:  Acta Neuropathol       Date:  2016-10-27       Impact factor: 17.088

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  1 in total

1.  The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study.

Authors:  Francesco Crescenzo; Damiano Marastoni; Anna Isabella Pisani; Agnese Tamanti; Caterina Dapor; Annalisa Colombi; Alessandro Brillo; Roberta Magliozzi; Francesca Benedetta Pizzini; Marco Castellaro; Massimiliano Calabrese
Journal:  Diagnostics (Basel)       Date:  2021-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.